Anti-SARS-CoV-2 seroprevalence in King County, WA-Cross-sectional survey, August 2020

被引:2
|
作者
Cowgill, Karen D. [1 ]
Erosheva, Elena A. [2 ,3 ]
Elder, Adam [4 ]
Miljacic, Ljubomir [5 ]
Buskin, Susan [6 ,7 ]
Duchin, Jeffrey S. [6 ,7 ,8 ]
机构
[1] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA
[2] Univ Washington, Sch Social Work, Dept Stat, Seattle, WA 98195 USA
[3] Univ Washington, Ctr Stat & Social Sci, Seattle, WA 98195 USA
[4] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA
[5] Mt Whisper Light, Seattle, WA USA
[6] Publ Hlth Seattle & King Cty, Seattle, WA USA
[7] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA
[8] Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA
来源
PLOS ONE | 2022年 / 17卷 / 08期
关键词
D O I
10.1371/journal.pone.0272783
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We conducted a seroprevalence survey to estimate the true number of infections with SARS-CoV-2, the virus that causes COVID-19, in King County as of August 2020 by measuring the proportion of residents from who had antibodies against the virus. Participants from 727 households took part in a cross-sectional address-based household survey with random and non-random samples and provided dried blood spots that were tested for total antibody against the viral nucleocapsid protein, with confirmatory testing for immunoglobulin G against the spike protein. The data were weighted to match King County's population based on sex, age group, income, race, and Hispanic status. After weighting and accounting for the accuracy of the tests, our best overall estimate of anti-SARS-CoV-2 seroprevalence in King County as of August 2020 is 3.9% (95% confidence interval (CI) 2.4%-6.0%) with an effective sample size of 589. Comparing seroprevalence with positive test reports, our survey suggests that viral testing underestimated incidence by a factor of about five and suggests that the proportion of cases that were serious (based on hospitalization) or fatal was 2.4% and 0.8%, respectively. Prevalence varied by subgroup; households reporting incomes at or below $100,000 in 2019 had nearly five times higher estimated antibody prevalence than those with incomes above $100,000. Those reporting non-White/non-Asian race had roughly seven times higher estimated antibody prevalence than those reporting White race. This survey was noteworthy for including people of all ages; among all age groups, the weighted estimate of prevalence was highest in older teens and young adults and lowest in young children, although these differences were not statistically significant.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
    Hiki, Makoto
    Tabe, Yoko
    Ai, Tomohiko
    Matsue, Yuya
    Harada, Norihiro
    Sugimoto, Kiichi
    Matsushita, Yasushi
    Matsushita, Masakazu
    Wakita, Mitsuru
    Misawa, Shigeki
    Idei, Mayumi
    Miida, Takashi
    Tamura, Naoto
    Takahashi, Kazuhisa
    Naito, Toshio
    PLOS ONE, 2021, 16 (04):
  • [22] High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
    Tesfaye Gelanew
    Berhanu Seyoum
    Andargachew Mulu
    Adane Mihret
    Markos Abebe
    Liya Wassie
    Baye Gelaw
    Abebe Sorsa
    Yared Merid
    Yilkal Muchie
    Zelalem Teklemariam
    Bezalem Tesfaye
    Mahlet Osman
    Gutema Jebessa
    Abay Atinafu
    Tsegaye Hailu
    Antenehe Habte
    Dagaga Kenea
    Anteneh Gadisa
    Desalegn Admasu
    Emnet Tesfaye
    Timothy A. Bates
    Jote Tafese Bulcha
    Rea Tschopp
    Dareskedar Tsehay
    Kim Mullholand
    Rawleigh Howe
    Abebe Genetu
    Fikadu G. Tafesse
    Alemseged Abdissa
    BMC Infectious Diseases, 22
  • [23] Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina
    Gashi, Bujar
    Osmani, Vesa
    Halili, Rrezart
    Hoxha, Teuta
    Kamberi, Agron
    Hoti, Nexhmedin
    Agahi, Riaz
    Basha, Vlora
    Berisha, Visar
    Hoxha, Ilir
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (23)
  • [24] Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimates
    Dopico, Xaquin Castro
    Muschiol, Sandra
    Grinberg, Nastasiya F.
    Aleman, Soo
    Sheward, Daniel J.
    Hanke, Leo
    Ahl, Marcus
    Vikstrom, Linnea
    Forsell, Mattias
    Coquet, Jonathan M.
    McInerney, Gerald
    Dillner, Joakim
    Bogdanovic, Gordana
    Murrell, Ben
    Albert, Jan
    Wallace, Chris
    Hedestam, Gunilla B. Karlsson
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2022, 11 (03)
  • [25] Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
    He, Zhenyu
    Ren, Lili
    Yang, Juntao
    Guo, Li
    Feng, Luzhao
    Ma, Chao
    Wang, Xia
    Leng, Zhiwei
    Tong, Xunliang
    Zhou, Wang
    Wang, Geng
    Zhang, Ting
    Guo, Yan
    Wu, Chao
    Wang, Qing
    Liu, Manqing
    Wang, Conghui
    Jia, Mengmeng
    Hu, Xuejiao
    Wang, Ying
    Zhang, Xingxing
    Hu, Rong
    Zhong, Jingchuan
    Yang, Jin
    Dai, Juan
    Chen, Lan
    Zhou, Xiaoqi
    Wang, Jianwei
    Yang, Weizhong
    Wang, Chen
    LANCET, 2021, 397 (10279): : 1075 - 1084
  • [26] Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study
    Lombardi, Andrea
    Mangioni, Davide
    Consonni, Dario
    Cariani, Lisa
    Bono, Patrizia
    Cantu, Anna Paola
    Tiso, Basilio
    Carugno, Michele
    Muscatello, Antonio
    Lunghi, Giovanna
    Pesatori, Angela Cecilia
    Riboldi, Luciano
    Ceriotti, Ferruccio
    Bandera, Alessandra
    Gori, Andrea
    BMJ OPEN, 2021, 11 (02):
  • [27] Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study
    Ghate, Manisha
    Shidhaye, Pallavi
    Gurav, Shraddha
    Gadhe, Keshav
    Kale, Varsha
    Jain, Preeti
    Thakar, Madhuri
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2022, 21
  • [28] A Cross-Sectional Study of SARS-CoV-2 Seroprevalence between Fall 2020 and February 2021 in Allegheny County, Western Pennsylvania, USA
    Xu, Lingqing
    Doyle, Joshua
    Barbeau, Dominique J.
    Le Sage, Valerie
    Wells, Alan
    Duprex, W. Paul
    Shurin, Michael R.
    Wheeler, Sarah E.
    McElroy, Anita K.
    PATHOGENS, 2021, 10 (06):
  • [29] Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study
    Beaumont, Adeline
    Durand, Cecile
    Ledrans, Martine
    Schwoebel, Valerie
    Noel, Harold
    Le Strat, Yann
    Diulius, Donatien
    Colombain, Lea
    Medus, Marie
    Gueudet, Philippe
    Mouly, Damien
    Aumaitre, Hugues
    BMJ OPEN, 2021, 11 (11):
  • [30] Estimation of Anti-SARS-CoV-2 IgM/IgG Seroprevalence Among Non-Vaccinated and Vaccinated University Students: A Cross-Sectional Egyptian Study
    Taha, Ahmed E.
    Amer, Ibrahim
    El Sharawy, Shimaa
    Ghazy, Amany A.
    VIRUSES-BASEL, 2025, 17 (03):